Nature, Published online: 20 February 2026; doi:10.1038/d41586-026-00552-6

The United Kingdom and Brazil have issued warnings about a possible link between GLP-1 weight-loss drugs and pancreatic inflammation, but the connection is murky.


From Nature via this RSS feed